TD Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Buy |
680
+552
| +431% | +$103K | 0.01% | 146 |
|
|
2025
Q1 | $26.8K | Buy |
128
+58
| +83% | +$12.1K | ﹤0.01% | 231 |
|
|
2024
Q4 | $12.5K | Buy |
70
+16
| +30% | +$2.85K | ﹤0.01% | 272 |
|
|
2024
Q3 | $10.8K | Hold |
54
| – | – | ﹤0.01% | 284 |
|
|
2024
Q2 | $9.27K | Hold |
54
| – | – | ﹤0.01% | 283 |
|
|
2024
Q1 | $9.75K | Buy |
54
+1
| +2% | +$181 | ﹤0.01% | 286 |
|
|
2023
Q4 | $8.22K | Sell |
53
-340
| -87% | -$52.8K | ﹤0.01% | 296 |
|
|
2023
Q3 | $58.5K | Buy |
393
+4
| +1% | +$596 | 0.01% | 161 |
|
|
2023
Q2 | $52.4K | Buy |
389
+3
| +0.8% | +$404 | 0.01% | 171 |
|
|
2023
Q1 | $61.4K | Sell |
386
-21
| -5% | -$3.34K | 0.01% | 161 |
|
|
2022
Q4 | $65.7K | Buy |
407
+29
| +8% | +$4.68K | 0.01% | 144 |
|
|
2022
Q3 | $51K | Buy |
+378
| New | +$51K | 0.01% | 159 |
|
|
2022
Q1 | – | Sell |
-439
| Closed | -$59K | – | 95 |
|
|
2021
Q4 | $59K | Sell |
439
-106
| -19% | -$14.2K | 0.01% | 152 |
|
|
2021
Q3 | $59K | Buy |
545
+4
| +0.7% | +$433 | 0.01% | 145 |
|
|
2021
Q2 | $61K | Buy |
541
+5
| +0.9% | +$564 | 0.01% | 135 |
|
|
2021
Q1 | $58K | Buy |
536
+126
| +31% | +$13.6K | 0.01% | 130 |
|
|
2020
Q4 | $44K | Buy |
410
+5
| +1% | +$537 | 0.01% | 135 |
|
|
2020
Q3 | $35K | Buy |
+405
| New | +$35K | 0.01% | 133 |
|
|
2019
Q3 | – | Sell |
-455
| Closed | -$33K | – | 259 |
|
|
2019
Q2 | $33K | Buy |
+455
| New | +$33K | 0.01% | 123 |
|
|
2017
Q4 | – | Sell |
-112
| Closed | -$10K | – | 183 |
|
|
2017
Q3 | $10K | Buy |
+112
| New | +$10K | ﹤0.01% | 134 |
|